-
Mashup Score: 5Understanding ATTR: The Challenges of Amyloidosis - 1 month(s) ago
Transthyretin amyloidosis (ATTR) is a complex medical condition that happens when a protein called transthyretin (TTR) does something different than what it’s supposed to do in the body. Normally, TTR is a four-piece protein produced mostly in the liver that helps carry important substances, like thyroxine (thyroid hormones) and vitamin A, throughout the body. When someone has ATTR, the pieces of TTR fall apart, misfold, and change shape. These pieces bind together to form larger structures called
Source: www.astrazeneca-us.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 8Understanding ATTR: The Challenges of Amyloidosis - 4 month(s) ago
ATTR (transthyretin amyloidosis) is a complex medical condition that happens when a protein called transthyretin (TTR) does something different than what it’s supposed to do in the body. Normally, TTR is a four-piece protein produced mostly in the liver that helps carry important substances, like thyroxine (thyroid hormones) and vitamin A, throughout the body. When someone has ATTR, the pieces of TTR fall apart, misfold, and change shape. These pieces bind together to form larger structures called
Source: www.astrazeneca-us.comCategories: General Medicine News, PayerTweet-
#ATTR symptoms can mirror other, more common medical conditions, leading to misdiagnosis and making the journey to treatment challenging. Learn more here: https://t.co/O3nRTJPqAa https://t.co/e72MNAAoej
-
-
Mashup Score: 1FDA Issues Complete Response Letter for Patisiran for Treatment of Cardiomyopathy of ATTR Amyloidosis - 7 month(s) ago
This letter denies approval for the treatment after results from the readout of the APOLLO-B Phase 3 study demonstrated limited efficacy in patients with ATTR amyloidosis with cardiomyopathy relative to placebo.
Source: arci.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The @US_FDA has issued a complete response letter for #Patisiran for the treatment of cardiomyopathy of #ATTR amyloidosis. Learn more about this disappointing news: https://t.co/GC59yfSnCX
-
-
Mashup Score: 26Vascular Amyloid Deposition Is Highly Prevalent in Immunoglobulin Light Chain Cardiac Amyloidosis: - 8 month(s) ago
Copyright © 2023, American College of Cardiology Foundation. Published by Elsevier Published online April 12,
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
ICYMI: RV biopsy vascular amyloid deposition is highly associated w/ AL cardiac #amyloidosis compared to #ATTR. Acceleration of microvascular disease may ➡️ early symptom onset in AL amyloid. https://t.co/Oysgi4mXoT #JACCIMG #CardioTwitter #CardioOnc @RNijveldt @raafs_anne https://t.co/wUwlV8G1rl
-
-
Mashup Score: 13D Video Understanding ATTR Amyloidosis - 8 month(s) ago
In ATTR amyloidosis, abnormal, unstable Transthyretin (TTR) proteins readily misfold, forming aggregates which deposit as “amyloid” in various organs and tis…
Source: www.youtube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In #ATTR #amyloidosis, abnormal, unstable Transthyretin (TTR) proteins readily misfold, forming aggregates which deposit as "amyloid" in various organs and tissues in the body. Learn more from this helpful explainer: https://t.co/AXHUwAeu01
-
-
Mashup Score: 3ARC TALKS Webinar: Kidney Disease Presentation in Amyloidosis - 8 month(s) ago
In this ARC Talks webinar, nephrologist Dr. Nelson Leung will focus on the implications of kidney involvement in amyloidosis patients …
Source: arci.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Happening Now! Don't miss Dr. Nelson Leung speaking about the implications of kidney involvement in #amyloidosis patients with #AL, #ATTR, #AA, #ALECT2, and other forms: https://t.co/6qWfeWsRzL https://t.co/ZqtDfJMNqs
-
-
Mashup Score: 2ARC TALKS Webinar: Kidney Disease Presentation in Amyloidosis - 8 month(s) ago
In this ARC Talks webinar, nephrologist Dr. Nelson Leung will focus on the implications of kidney involvement in amyloidosis patients …
Source: arci.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📅 #ARCTALKS Webinar: Monday, August 21 Leading #nephrologist Dr. Nelson Leung will focus on the implications of kidney involvement in #amyloidosis patients with #AL, #ATTR, #AA, #ALECT2, and other forms: https://t.co/6qWfeWsRzL
-
-
Mashup Score: 18Vascular Amyloid Deposition Is Highly Prevalent in Immunoglobulin Light Chain Cardiac Amyloidosis: - 8 month(s) ago
Copyright © 2023, American College of Cardiology Foundation. Published by Elsevier Published online April 12,
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
RV biopsy vascular amyloid deposition is highly associated w/ AL cardiac #amyloidosis compared to #ATTR. Acceleration of microvascular disease may ➡️ early symptom onset in AL amyloid. https://t.co/Oysgi4mXoT #JACCIMG #CardioTwitter #cvImaging #CardioOnc @RNijveldt @raafs_anne https://t.co/dhDNQDyJFO
-
-
Mashup Score: 1Prospective Screening for Transthyretin Cardiac Amyloidosis in Spinal Stenosis Surgery Patients: Results of the CASS Study - 9 month(s) ago
Symptomatic lumbar spinal stenosis (SS) related to ligamentum flavum (LF) hypertrophy has b een associated with transthyretin amyloid (ATTR) deposition. 1 Moreover, SS precedes a diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) in up to 40% on average 5 to 15 years prior. 2 Yet, prospective data on systematic screening for concomitant ATTR-CM in patients undergoing SS surgery are scarce. Studies have reported an ATTR-CM prevalence of 0% to 10% of patients with ATTR amyloid positive LF biopsy
Source: www.jacc.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Our #ATTR Patient Experience Study found 48% of patients w/#ATTR reported having been diagnosed with spinal stenosis. We must continue investigating the best course of monitoring and action for those with red-flag symptoms but without cardiac involvement. https://t.co/14GmSpOuwt https://t.co/rajzIEkELP
-
-
Mashup Score: 1ARC 2022 Community Survey Results - 9 month(s) ago
Over 1200 responses were completed for the 2022 ARC Community Survey during April and May of that year. 79% of participants identified …
Source: arci.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We'd like to take a moment and thank the organizations that supported our 2022 #amyloidosis Community Survey. Without them, this critical insight into the impact of #AL #ATTR #AA and other types wouldn't have been possible: https://t.co/lMV2pZxHyD
-
We’re committed to pushing scientific progress of transthyretin amyloidosis (ATTR), championing early diagnosis and empowering patients through education. Join us in raising #ATTR awareness this Amyloidosis Awareness Month. Learn more: https://t.co/f9xe90m3Yy https://t.co/JeJA2JY8jg